Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Klotho Neurosciences Signs Letter of Intent To Acquire Assets From Turn Biotechnologies, Including Turn's Epigenetic Reprogramming of Age Platform And eTurna RNA Delivery System As Well As Co-Development Partnership Worth Up To $300M

Author: Benzinga Newsdesk | September 30, 2025 08:33am

Posted In: KLTO